A rapid assay to screen for drug-resistant herpes simplex virus

Journal of Infectious Diseases

Volumn 177, Issue 1, 1998, Pages 217-220

  Tebas, P ^b   Scholl, D ^b   Jollick, J ^b   McHarg, K ^b   Arens, M ^b   Olivo, P D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HERPES; HERPES SIMPLEX VIRUS; NONHUMAN; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS ISOLATION;

EID: 0031985656     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517357     Document Type: Article

References (14)

1. Whitley RJ. Herpes simplex viruses. In: Fields BN, Knipe DM, Howley PM, eds. Virology. 3rd ed. Vol 2. New York: Lippincott-Raven, 1996:2297-342.
2. Straus SE, Smith HA, Brickman C, de Miranda P, McLaren C, Keeney RE. Acyclovir for chronic mucocutaneous herpes simplex virus infection in immunosuppressed patients. Ann Intern Med 1982;96:270-7.
3. Coen DM. Resistance of herpes simplex virus to antiviral drugs. Curr Opin Infect Dis 1995;8:489-92.
4. Chatis PA, Crumpacker CS. Resistance of herpesviruses to antiviral drugs [review]. Antimicrob Agents Chemother 1992;36:1589-95.
5. Coen DM. Acyclovir-resistant, pathogenic herpesviruses [review]. Trends Microbiol 1994;2:481-5.
6. Field AK, Biron KK. "The end of innocence" revisited: resistance of herpesviruses to antiviral drugs [review]. Clin Microbiol Rev 1994;7:1-13.
7. Swierkosz EM, Biron KK. Antiviral susceptibility testing. In: Lennette EH, Lennette DA, Lennette ET, eds. Diagnostic procedures for viral, rickettsial, and chlamydial infections. 7th ed. Washington, DC: American Public Health Association, 1995:139-54.
8. Standring CR, Bacon TH, Howard BA. Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir. J Virol Methods 1996;56:3-11.
9. Safrin S, Palacios EB, Leahy J. Comparative evaluation of microplate enzyme-linked immunosorbent assay versus plaque reduction assay for antiviral susceptibility testing of herpes simplex virus isolates. Antimicrob Agents Chemother 1996;40:1017-9.
10. Leahy BJ, Christiansen KJ, Collins P. A blinded comparison of two methods of viral susceptibility testing: plaque reduction assay versus microplate in situ ELISA. J Virol Methods 1996;56:85-90.
11. Tebas P, Stabell ES, Olivo PD. Antiviral susceptibility testing with a cell line that expresses β-galactosidase after infection with herpes simplex virus. Antimicrob Agents Chemother 1995;39:1287-91.
12. Scholl DR, Dul JD, McHarg KD, Jollick JD, August M, Callon DF. ELVIRA™ HSV promoter cell clone for rapid antiviral resistance testing [abstract M29]. In: Program and abstracts of the twelfth annual clinical virology symposium and annual meeting of the Pan American Society for Clinical Virology (Clearwater Beach, FL), 1996:126.
13. Safrin S, Palacios E, Leahy BJ. Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 1994;38:1246-50.
14. Roizman B, Sears AE. Herpes simplex viruses and their replication. In: Fields BN, Knipe DM, Howley PM, eds. Virology. 3rd ed. Vol 2. New York: Lippincott-Raven, 1996:2231-96.